Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy's Lab gets EIR for API manufacturing at Hyderabad

Date: 07-10-2019

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its API manufacturing plant 2 at Bollaram in the state of Hyderabad, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.